{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,15]],"date-time":"2026-03-15T16:09:38Z","timestamp":1773590978298,"version":"3.50.1"},"reference-count":89,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","contraceptionjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.contraception.2021.03.016","type":"journal-article","created":{"date-parts":[[2021,3,22]],"date-time":"2021-03-22T22:23:43Z","timestamp":1616451823000},"page":"119-127","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Society of Family Planning clinical recommendations: Management of individuals with bleeding or thrombotic disorders undergoing abortion"],"prefix":"10.1016","volume":"104","author":[{"given":"Jessica K.","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann B.","family":"Zimrin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolyn","family":"Sufrin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2021.03.016_bib0001","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1538-7836.2008.02921.x","article-title":"Pregnancy, the postpartum period and prothrombotic defects: risk of venous thrombosis in the MEGA study","volume":"6","author":"Pomp","year":"2008","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.contraception.2021.03.016_bib0002","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ijgo.2015.06.054","article-title":"A systematic review and meta-analysis of the epidemiology and burden of venous thromboembolism among pregnant women","volume":"132","author":"Kourlaba","year":"2016","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.contraception.2021.03.016_bib0003","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/bdrc.21105","article-title":"Epidemiology of venous thromboembolism (VTE) associated with pregnancy","volume":"105","author":"Parunov","year":"2015","journal-title":"Birth Defects Res C Embryo Today"},{"key":"10.1016\/j.contraception.2021.03.016_bib0004","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.thromres.2004.08.004","article-title":"Haemostatic changes in pregnancy","volume":"114","author":"Brenner","year":"2004","journal-title":"Thromb Res"},{"key":"10.1016\/j.contraception.2021.03.016_bib0005","series-title":"Obstetrics: normal and problem pregnancies","author":"Gabbe","year":"2017"},{"key":"10.1016\/j.contraception.2021.03.016_bib0006","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S1521-6926(03)00021-5","article-title":"Haemostatic changes in pregnancy","volume":"16","author":"Bremme","year":"2003","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.contraception.2021.03.016_bib0007","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1538-7836.2009.03661.x","article-title":"The prevalence of symptomatic von Willebrand disease in primary care practice","volume":"8","author":"Bowman","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.contraception.2021.03.016_bib0008","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/MBC.0b013e3282f09835","article-title":"Haemostatic changes and acquired activated protein C resistance in normal pregnancy","volume":"18","author":"Mahieu","year":"2007","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.contraception.2021.03.016_bib0009","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1056\/NEJMoa1802897","article-title":"Platelet counts during pregnancy","volume":"379","author":"Reese","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.contraception.2021.03.016_bib0010","doi-asserted-by":"crossref","first-page":"e181","DOI":"10.1097\/AOG.0000000000003100","article-title":"Thrombocytopenia in Pregnancy. ACOG practice bulletin No. 207. American College of Obstetricians and Gynecologists","volume":"133","year":"2019","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2021.03.016_bib0011","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1182\/asheducation-2016.1.663","article-title":"Treatment of rare factor deficiencies in 2016","volume":"2016","author":"Peyvandi","year":"2016","journal-title":"Hematol Am Soc Hematol Educ Progr"},{"key":"10.1016\/j.contraception.2021.03.016_bib0012","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s004390100593","article-title":"Genetic risk factors of venous thrombosis","volume":"109","author":"Franco","year":"2001","journal-title":"Hum Genet"},{"key":"10.1016\/j.contraception.2021.03.016_bib0013","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1182\/blood-2002-01-0149","article-title":"Temporary increase in the risk for recurrence during pregnancy in women with a history of venous thromboembolism","volume":"100","author":"Pabinger","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.contraception.2021.03.016_bib0014","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.maturitas.2015.08.014","article-title":"Practice points in gynecardiology: abnormal uterine bleeding in premenopausal women taking oral anticoagulant or antiplatelet therapy","volume":"82","author":"Maas","year":"2015","journal-title":"Maturitas"},{"key":"10.1016\/j.contraception.2021.03.016_bib0015","first-page":"14","article-title":"Blood loss at the time of surgical abortion up to 14 weeks in anticoagulated patients: a case series","volume":"96","author":"Kaneshiro","year":"2017","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2021.03.016_bib0016","series-title":"Safe abortion: technical and policy guidance for health systems","year":"2012"},{"key":"10.1016\/j.contraception.2021.03.016_bib0017","first-page":"197","article-title":"Blood loss in therapeutic abortion by vacuum aspiration in multigravidae","volume":"4","author":"Sandstrom","year":"1976","journal-title":"IRCS Med Sci Cardiovasc Syst"},{"issue":"1","key":"10.1016\/j.contraception.2021.03.016_bib0018","first-page":"129","article-title":"Complications of first-trimester abortion: a report of 170,000 cases","volume":"76","author":"Hakim-Elahi","year":"1990","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.contraception.2021.03.016_bib0019","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/AOG.0000000000000603","article-title":"Incidence of emergency department visits and complications after abortion","volume":"125","author":"Upadhyay","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2021.03.016_bib0020","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/AOG.0b013e3182755763","article-title":"Significant adverse events and outcomes after medical abortion","volume":"121","author":"Cleland","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2021.03.016_bib0021","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1093\/humrep\/17.11.2865","article-title":"A prospective randomized study on the measured blood loss in medical termination of early pregnancy by three different misoprostol regimens after pretreatment with mifepristone","volume":"17","author":"Tang","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2021.03.016_bib0022","first-page":"141","article-title":"Bleeding patterns after early abortion with mifepristone and misoprostol or manual vacuum aspiration","volume":"55","author":"Davis","year":"2000","journal-title":"J Am Med Womens Assoc"},{"key":"10.1016\/j.contraception.2021.03.016_bib0023","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.contraception.2010.09.009","article-title":"Blood loss at the time of first-trimester surgical abortion in anticoagulated women","volume":"83","author":"Kaneshiro","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2021.03.016_bib0024","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.contraception.2012.10.024","article-title":"Management of postabortion hemorrhage: release date November 2012 SFP Guideline #20131","volume":"87","author":"Kerns","year":"2013","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2021.03.016_bib0025","first-page":"601","article-title":"Midtrimester abortion with Laminaria and vacuum evacuation on a teaching service","volume":"30","author":"Altman","year":"1985","journal-title":"J Reprod Med"},{"key":"10.1016\/j.contraception.2021.03.016_bib0026","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.contraception.2006.03.021","article-title":"Introduction of the dilation and evacuation procedure for second-trimester abortion in Vietnam using manual vacuum aspiration and buccal misoprostol","volume":"74","author":"Castleman","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2021.03.016_bib0027","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1097\/AOG.0b013e3181d43f42","article-title":"Effect of prior cesarean delivery on risk of second-trimester surgical abortion complications","volume":"115","author":"Frick","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2021.03.016_bib0028","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.contraception.2005.10.004","article-title":"Adequacy and safety of buccal misoprostol for cervical preparation prior to termination of second-trimester pregnancy","volume":"73","author":"Patel","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2021.03.016_bib0029","first-page":"185","article-title":"Second-trimester abortion by dilatation and evacuation: an analysis of 11,747 cases","volume":"62","author":"Peterson","year":"1983","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2021.03.016_bib0030","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.contraception.2018.01.008","article-title":"Estimated versus measured blood loss during dilation and evacuation: an observational study","volume":"97","author":"Serapio","year":"2018","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2021.03.016_bib0031","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1067\/mob.2002.123887","article-title":"A comparison of medical induction and dilation and evacuation for second-trimester abortion","volume":"187","author":"Autry","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2021.03.016_bib0032","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.contraception.2006.11.001","article-title":"Effect of placenta previa on blood loss in second-trimester abortion by labor induction using gemeprost","volume":"75","author":"Nakayama","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2021.03.016_bib0033","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.contraception.2017.09.002","article-title":"Blood loss at the time of dilation and evacuation at 16 to 22 weeks of gestation in women using low molecular weight heparin: a case series","volume":"97","author":"Tschann","year":"2018","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2021.03.016_bib0034","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.contraception.2011.02.005","article-title":"Society of family planning. Labor induction abortion in the second-trimester","volume":"84","author":"Borgatta","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2021.03.016_bib0035","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.contraception.2012.09.001","article-title":"First-trimester abortion in women with medical conditions","volume":"86","author":"Guiahi","year":"2012","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2021.03.016_bib0036","unstructured":"Signs and symptoms of bleeding disorders in women | CDC. https:\/\/www.cdc.gov\/ncbddd\/blooddisorders\/women\/symptoms.html (Accessed April 15, 2019)."},{"key":"10.1016\/j.contraception.2021.03.016_bib0037","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.contraception.2007.11.004","article-title":"Second-trimester termination of pregnancy: a review by site and procedure type","volume":"77","author":"Turok","year":"2008","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2021.03.016_bib0038","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1001\/jama.2018.7675","article-title":"Association of facility type with procedural-related morbidities and adverse events among patients undergoing induced abortions","volume":"319","author":"Roberts","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.contraception.2021.03.016_bib0039","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.contraception.2015.07.013","article-title":"Complications from first-trimester aspiration abortion: a systematic review of the literature","volume":"92","author":"White","year":"2015","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2021.03.016_bib0040","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.athoracsur.2010.11.078","article-title":"2011 update to The Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines","volume":"91","author":"Ferraris","year":"2011","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.contraception.2021.03.016_bib0041","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0140-6736(85)92496-1","article-title":"Vasopressin reduces blood loss from second-trimester dilatation and evacuation abortion","volume":"2","author":"Schulz","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2021.03.016_bib0042","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/AOG.0000000000003104","article-title":"Effects of Prophylactic oxytocin on bleeding outcomes in women undergoing dilation and evacuation: a randomized controlled trial","volume":"133","author":"Whitehouse","year":"2019","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2021.03.016_bib0043","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.contraception.2018.03.020","article-title":"The UP trial: a randomized controlled trial of uterotonic prophylaxis with methylergonovine maleate for late dilation and evacuation abortions","volume":"97","author":"Kerns","year":"2018","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2021.03.016_bib0044","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/00005373-198203000-00003","article-title":"Passive leg raising does not produce a significant or sustained autotransfusion effect","volume":"22","author":"Gaffney","year":"1982","journal-title":"J Trauma"},{"key":"10.1016\/j.contraception.2021.03.016_bib0045","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12871-015-0055-3","article-title":"Lithotomy versus jack-knife position on haemodynamic parameters assessed by impedance cardiography during anorectal surgery under low dose spinal anaesthesia: a randomized controlled trial","volume":"15","author":"Borodiciene","year":"2015","journal-title":"BMC Anesthesiol"},{"key":"10.1016\/j.contraception.2021.03.016_bib0046","doi-asserted-by":"crossref","first-page":"e120","DOI":"10.1097\/AOG.0000000000002818","article-title":"Perioperative pathways: enchanced recovery after surgery. ACOG Committee Opinion No. 750. American College of Obstetricians and Gynecologists","volume":"132","year":"2018","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2021.03.016_bib0047","doi-asserted-by":"crossref","DOI":"10.1378\/chest.11-2295","article-title":"Evidence-based management of anticoagulant therapy","volume":"141","author":"Holbrook","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.contraception.2021.03.016_bib0048","first-page":"856","article-title":"ACOG Committee Opinion No 610. American College of Obstetricians and Gynecologists","volume":"124","year":"2014","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2021.03.016_bib0049","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1097\/SLA.0000000000002126","article-title":"Individualized venous thromboembolism risk stratification using the 2005 caprini score to identify the benefits and harms of chemoprophylaxis in surgical patients","volume":"265","author":"Pannucci","year":"2017","journal-title":"Ann Surg"},{"key":"10.1016\/j.contraception.2021.03.016_bib0050","doi-asserted-by":"crossref","DOI":"10.1378\/chest.08-0689","article-title":"Parenteral anticoagulants: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"133","author":"Hirsh","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.contraception.2021.03.016_bib0051","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/jth.13670","article-title":"Thrombotic and bleeding outcomes following perioperative interruption of direct oral anticoagulants in patients with venous thromboembolic disease","volume":"15","author":"Shaw","year":"2017","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.contraception.2021.03.016_bib0052","doi-asserted-by":"crossref","first-page":"4699","DOI":"10.1182\/blood-2012-05-423228","article-title":"Perioperative management of patients on chronic antithrombotic therapy","volume":"120","author":"Ortel","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.contraception.2021.03.016_bib0053","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/AOG.0000000000002706","article-title":"Thromboembolism in pregnancy. ACOG Practice Bulletin No. 196. American College of Obstetricians and Gynecologists","volume":"132","year":"2018","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2021.03.016_bib0054","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S1701-2163(15)30569-7","article-title":"Venous thromboembolism and antithrombotic therapy in pregnancy","volume":"36","author":"Chan","year":"2014","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.contraception.2021.03.016_bib0055","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1213\/ANE.0000000000002530","article-title":"The Society for Obstetric Anesthesia and Perinatology consensus statement on the anesthetic management of pregnant and postpartum women receiving thromboprophylaxis or higher dose anticoagulants","volume":"126","author":"Leffert","year":"2018","journal-title":"Anesth Analg"},{"key":"10.1016\/j.contraception.2021.03.016_bib0056","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1056\/NEJM199705223362107","article-title":"Management of anticoagulation before and after elective surgery","volume":"336","author":"Kearon","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.contraception.2021.03.016_bib0057","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1365-2796.2005.01477.x","article-title":"Low-dose aspirin for secondary cardiovascular prevention - cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation - review and meta-analysis","volume":"257","author":"Burger","year":"2005","journal-title":"J Intern Med"},{"key":"10.1016\/j.contraception.2021.03.016_bib0058","doi-asserted-by":"crossref","DOI":"10.1378\/chest.11-2298","article-title":"Perioperative management of antithrombotic therapy","volume":"141","author":"Douketis","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.contraception.2021.03.016_bib0059","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.contraception.2012.09.001","article-title":"Society of Family Planning. First-trimester abortion in women with medical conditions. SFP guideline #20122","volume":"86","author":"Guiahi","year":"2012","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2021.03.016_bib0060","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1783\/jfp.34.2.93","article-title":"Gynaecological problems and choices for contraception in women with inherited bleeding disorders","volume":"34","author":"Burton","year":"2008","journal-title":"J Fam Plan Reprod Heal Care"},{"key":"10.1016\/j.contraception.2021.03.016_bib0061","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.contraception.2010.02.014","article-title":"Adaptation of the World Health Organization's medical eligibility criteria for contraceptive use for use in the United States","volume":"82","author":"Curtis","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2021.03.016_bib0062","first-page":"74","article-title":"The effectiveness of the levonorgestrel-releasing intrauterine system in menorrhagia: a systematic review","volume":"108","author":"Stewart","year":"2001","journal-title":"BJOG"},{"key":"10.1016\/j.contraception.2021.03.016_bib0063","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1111\/j.1471-0528.2004.00305.x","article-title":"The use of levonorgestrel-releasing intrauterine system for treatment of menorrhagia in women with inherited bleeding disorders","volume":"111","author":"Kingman","year":"2004","journal-title":"BJOG"},{"key":"10.1016\/j.contraception.2021.03.016_bib0064","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.fertnstert.2007.07.1315","article-title":"Use of the levonorgestrel-releasing intrauterine system in women with hemostatic disorders","volume":"90","author":"Lukes","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2021.03.016_bib0065","doi-asserted-by":"crossref","first-page":"S123","DOI":"10.1016\/j.contraception.2007.01.005","article-title":"Levonorgestrel intrauterine system: bleeding disorders and anticoagulant therapy","volume":"75","author":"Kadir","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2021.03.016_bib0066","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.contraception.2010.07.010","article-title":"Levonorgestrel-releasing intrauterine system for the management of heavy menstrual bleeding in women with inherited bleeding disorders: long-term follow-up","volume":"83","author":"Chi","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2021.03.016_bib0067","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.ajog.2005.05.002","article-title":"The use of the levonorgestrel-releasing intrauterine system in the management of menorrhagia in women with hemostatic disorders","volume":"193","author":"Schaedel","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2021.03.016_bib0068","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1177\/0961203306071706","article-title":"Treatment of menorrhagia associated with oral anticoagulation: efficacy and safety of the levonorgestrel releasing intrauterine device (Mirena coil)","volume":"15","author":"Pisoni","year":"2006","journal-title":"Lupus"},{"key":"10.1016\/j.contraception.2021.03.016_bib0069","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.contraception.2009.04.008","article-title":"Use of contraceptive methods by women with current venous thrombosis on anticoagulant therapy: a systematic review","volume":"80","author":"Culwell","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2021.03.016_bib0070","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.14219\/jada.archive.2003.0080","article-title":"Lack of a scientific basis for routine discontinuation of oral anticoagulation therapy before dental treatment","volume":"134","author":"Jeske","year":"2003","journal-title":"J Am Dent Assoc"},{"issue":"5","key":"10.1016\/j.contraception.2021.03.016_bib0071","first-page":"730","article-title":"Incidence, clinical characteristics, and timing of objectively diagnosed venous thromboembolism during pregnancy","volume":"94","author":"Gherman","year":"1999","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2021.03.016_bib0072","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.ajog.2005.11.008","article-title":"Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality","volume":"194","author":"James","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2021.03.016_bib0073","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1093\/humrep\/dey271","article-title":"Low risk of venous thromboembolism following early pregnancy loss in pregnancies conceived by IVF","volume":"33","author":"Hansen","year":"2018","journal-title":"Hum Reprod"},{"issue":"5","key":"10.1016\/j.contraception.2021.03.016_bib0074","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1111\/j.1538-7836.2005.01307.x","article-title":"Risk of pregnancy-associated recurrent venous thromboembolism in women with a history of venous thrombosis","volume":"3","author":"Pabinger","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.contraception.2021.03.016_bib0075","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1097\/AOG.0000000000002703","article-title":"Inherited thrombophilias in pregnancy. ACOG Practice Bulletin No. 197. American College of Obstetricians and Gynecologists","volume":"132","year":"2018","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2021.03.016_bib0076","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1182\/bloodadvances.2018024802","article-title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy","volume":"2","author":"Bates","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.contraception.2021.03.016_bib0077","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1182\/asheducation-2014.1.387","article-title":"Pregnancy and venous thromboembolism: \u201cTIPPS\u201d for risk stratification","volume":"2014","author":"Rodger","year":"2014","journal-title":"Hematol Am Soc Hematol Educ Progr"},{"key":"10.1016\/j.contraception.2021.03.016_bib0078","doi-asserted-by":"crossref","first-page":"858","DOI":"10.7326\/0003-4819-135-10-200111200-00006","article-title":"Extended out-of-hospital low-molecular-weight heparin prophylaxis against deep venous thrombosis in patients after elective hip arthroplasty: a systematic review","volume":"135","author":"Hull","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.contraception.2021.03.016_bib0079","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0015-0282(16)44713-8","article-title":"Differences in hormonal patterns during the first postabortion menstrual cycle after two techniques of termination of pregnancy","volume":"33","author":"Blazar","year":"1980","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2021.03.016_bib0080","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/AOG.0000000000002706","article-title":"Thromboembolism in pregnancy. ACOG Practice Bulletin No. 196. American College of Obstetricians and Gynecologists","volume":"132","year":"2018","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2021.03.016_bib0081","series-title":"Thromboembolic disease in pregnancy and the puerperium: acute management. RCOG green-top guideline No. 37b","year":"2015"},{"key":"10.1016\/j.contraception.2021.03.016_bib0082","doi-asserted-by":"crossref","DOI":"10.1378\/chest.11-2300","article-title":"VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"141","author":"Bates","year":"2012","journal-title":"Chest"},{"issue":"6S","key":"10.1016\/j.contraception.2021.03.016_bib0083","doi-asserted-by":"crossref","first-page":"S437","DOI":"10.1097\/SAP.0000000000001898","article-title":"Hematoma risks of nonsteroidal anti-inflammatory drugs used in plastic surgery procedures: a systematic review and meta-analysis","volume":"82","author":"Walker","year":"2019","journal-title":"Ann Plast Surg"},{"key":"10.1016\/j.contraception.2021.03.016_bib0084","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2174\/1574886311666160719154420","article-title":"Safety considerations in the use of ketorolac for postoperative pain","volume":"12","author":"Maslin","year":"2017","journal-title":"Curr Drug Saf"},{"key":"10.1016\/j.contraception.2021.03.016_bib0085","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s11695-018-3608-y","article-title":"Safety and efficacy of non-steroidal anti-inflammatory drugs (NSAIDs) used for analgesia after bariatric surgery: a retrospective case-control study","volume":"29","author":"Abou Zeid","year":"2019","journal-title":"Obes Surg"},{"key":"10.1016\/j.contraception.2021.03.016_bib0086","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/j.1552-4604.1995.tb04050.x","article-title":"Effects of nonsteroidal antiinflammatory drugs on platelet function and systemic hemostasis","volume":"35","author":"Schafer","year":"1995","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.contraception.2021.03.016_bib0087","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1177\/003693308302800109","article-title":"Interaction between oral anti-coagulant drugs and non-steroidal anti-inflammatory agents: a review","volume":"28","author":"Pullar","year":"1983","journal-title":"Scott Med J"},{"key":"10.1016\/j.contraception.2021.03.016_bib0088","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1182\/asheducation-2018.1.339","article-title":"Drug-drug interactions in an era of multiple anticoagulants: a focus on clinically relevant drug interactions","volume":"2018","author":"Vazquez","year":"2018","journal-title":"Hematol Am Soc Hematol Educ Progr"},{"key":"10.1016\/j.contraception.2021.03.016_bib0089","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1136\/bmj.38828.593125.55","article-title":"Management of miscarriage: expectant, medical, or surgical? Results of randomised controlled trial (miscarriage treatment (MIST) trial)","volume":"332","author":"Trinder","year":"2006","journal-title":"BMJ"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782421000883?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782421000883?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T20:18:38Z","timestamp":1757881118000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782421000883"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":89,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S0010782421000883"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2021.03.016","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Society of Family Planning clinical recommendations: Management of individuals with bleeding or thrombotic disorders undergoing abortion","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2021.03.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}